Xencor, Inc.
US ˙ NasdaqGM ˙ US98401F1057

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Todd E Simpson. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Todd E Simpson har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:XNCR / Xencor, Inc. Director 13.686
US:SGEN / Seagen Inc Chief Financial Officer 0
US:NLTX / Neoleukin Therapeutics, Inc. Director 25.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Todd E Simpson. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb XNCR / Xencor, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i XNCR / Xencor, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XNCR / Xencor, Inc. Insider Trades
Insidersalg XNCR / Xencor, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i XNCR / Xencor, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XNCR / Xencor, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Todd E Simpson som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-16 2025-06-12 4 XNCR Xencor Inc
Common Stock
A - Award 13.686 13.686
2023-12-15 2023-12-14 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer -93.292 0 -100,00 229,00 -21.363.868
2023-09-22 2023-09-21 4 SGEN Seagen Inc.
Common Stock
S - Sale X -80 128.723 -0,06 206,50 -16.520 26.581.300
2023-09-01 2023-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2.122 128.803 -1,62 206,97 -439.182 26.657.829
2023-08-30 2023-08-29 4 SGEN Seagen Inc.
Common Stock
S - Sale X -485 130.925 -0,37 206,00 -99.910 26.970.550
2023-08-30 2023-08-28 4 SGEN Seagen Inc.
Common Stock
A - Award 1.225 131.410 0,94
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X -1.540 130.185 -1,17 193,87 -298.558 25.238.823
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X -861 131.725 -0,65 193,87 -166.921 25.537.381
2023-08-17 2023-08-16 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer X -1.106 132.586 -0,83 193,87 -214.419 25.704.302
2023-08-17 2023-08-15 4 SGEN Seagen Inc.
Common Stock
A - Award 14.746 133.692 12,40
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
S - Sale X -40.364 118.946 -25,34 204,74 -8.264.125 24.353.004
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
M - Exercise 40.364 159.310 33,93 46,37 1.871.679 7.387.205
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
S - Sale X -14.980 118.946 -11,19 204,14 -3.058.017 24.281.636
2023-04-12 2023-04-10 4 SGEN Seagen Inc.
Common Stock
M - Exercise 14.980 133.926 12,59 46,37 694.623 6.210.149
2023-04-07 2023-04-06 4 SGEN Seagen Inc.
Common Stock
S - Sale X -243 118.946 -0,20 205,86 -50.023 24.485.819
2023-04-07 2023-04-05 4 SGEN Seagen Inc.
Common Stock
A - Award 609 119.189 0,51
2023-04-04 2023-04-01 4 SGEN Seagen Inc.
Common Stock
A - Award 1.395 118.580 1,19
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X -6.082 117.185 -4,93 177,37 -1.078.764 20.785.103
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X -26.449 123.267 -17,67 176,71 -4.673.803 21.782.512
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
S - Sale X -10.262 149.716 -6,41 175,89 -1.804.983 26.333.547
2023-03-10 2023-03-09 4 SGEN Seagen Inc.
Common Stock
M - Exercise 42.793 159.978 36,52 45,30 1.938.523 7.247.003
2023-02-28 2023-02-27 4 SGEN Seagen Inc.
Common Stock
S - Sale X -20.000 117.185 -14,58 182,53 -3.650.600 21.389.778
2023-02-21 2023-02-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -39.946 137.185 -22,55 160,00 -6.391.400 21.949.737
2023-02-21 2023-02-16 4 SGEN Seagen Inc.
Common Stock
M - Exercise 39.946 177.131 29,12 39,15 1.563.886 6.934.679
2022-09-01 2022-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2.064 137.185 -1,48 154,41 -318.712 21.183.353
2022-09-01 2022-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2.122 139.249 -1,50 154,41 -327.668 21.502.065
2022-08-17 2022-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.106 141.371 -0,78 170,22 -188.258 24.063.479
2022-08-17 2022-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -861 142.477 -0,60 170,22 -146.555 24.251.737
2022-08-17 2022-08-15 4 SGEN Seagen Inc.
Common Stock
A - Award 15.447 143.338 12,08
2022-05-16 2022-05-12 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2022-04-22 2022-04-20 4 SGEN Seagen Inc.
Common Stock
S - Sale X -567 127.891 -0,44 144,32 -81.829 18.457.050
2021-12-22 2021-12-20 4 SGEN Seagen Inc.
Common Stock
S - Sale X -345 128.458 -0,27 149,85 -51.698 19.249.431
2021-11-05 2021-11-04 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
M - Exercise -2.156 0 -100,00
2021-11-05 2021-11-04 4 SGEN Seagen Inc.
Common Stock
M - Exercise 2.156 128.803 1,70 46,37 99.974 5.972.595
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -40.232 0 -100,00
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Common Stock
S - Sale X -40.232 126.647 -24,11 185,00 -7.442.920 23.429.695
2021-11-05 2021-11-03 4 SGEN Seagen Inc.
Common Stock
M - Exercise 40.232 166.879 31,77 44,09 1.773.829 7.357.695
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -33.564 0 -100,00
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Common Stock
S - Sale X -33.564 126.647 -20,95 180,00 -6.041.523 22.796.473
2021-11-02 2021-10-29 4 SGEN Seagen Inc.
Common Stock
M - Exercise 33.564 160.211 26,50 41,04 1.377.467 6.575.059
2021-09-27 2021-09-23 4 SGEN Seagen Inc.
Common Stock
A - Award 201 126.647 0,16 166,22 33.410 21.051.264
2021-09-02 2021-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -2.122 126.446 -1,65 167,52 -355.468 21.181.665
2021-09-02 2021-08-31 4 SGEN Seagen Inc.
Common Stock
S - Sale X -1.865 128.568 -1,43 167,52 -312.416 21.537.133
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
A - Award 26.427 26.427
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
A - Award 642 642
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Common Stock
A - Award 11.095 130.433 9,30
2021-08-18 2021-08-16 4 SGEN Seagen Inc.
Common Stock
S - Sale X -533 119.338 -0,44 154,55 -82.377 18.444.165
2021-05-13 2021-05-11 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
M - Exercise -33.669 0 -100,00
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Incentive Stock Option (right to buy)
M - Exercise -1.104 0 -100,00
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
M - Exercise 1.104 119.871 0,93 45,30 50.011 5.430.156
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
S - Sale X -33.669 118.767 -22,09 200,00 -6.733.800 23.753.400
2020-12-18 2020-12-18 4 SGEN Seagen Inc.
Common Stock
M - Exercise 33.669 152.436 28,35 26,10 878.761 3.978.580
2020-11-09 2020-11-05 4 SGEN Seagen Inc.
Common Stock
S - Sale -7.509 118.767 -5,95 180,37 -1.354.383 21.421.766
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -469 126.276 -0,37 159,33 -74.726 20.119.555
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -50 126.745 -0,04 157,82 -7.891 20.002.896
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1.640 126.795 -1,28 156,87 -257.267 19.890.332
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5.480 128.435 -4,09 155,74 -853.455 20.002.467
2020-09-02 2020-09-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4.452 133.915 -3,22 155,25 -691.173 20.790.304
2020-09-02 2020-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2.122 138.367 -1,51 155,69 -330.383 21.542.939
2020-09-02 2020-08-31 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2.065 140.489 -1,45 155,69 -321.509 21.873.322
2020-08-20 2020-08-18 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -9.262 142.554 -6,10 158,17 -1.464.959 22.547.595
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 20.774 20.774
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 636 636
2020-08-17 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 8.635 151.816 6,03
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1.905 143.181 -1,31 166,74 -317.640 23.874.000
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -10.375 145.086 -6,67 166,10 -1.723.288 24.098.785
2020-08-05 2020-08-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -7.720 155.461 -4,73 164,96 -1.273.491 25.644.847
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1.010 163.181 -0,62 171,39 -173.104 27.967.592
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -139 164.191 -0,08 170,18 -23.655 27.942.024
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5.012 164.330 -2,96 167,66 -840.312 27.551.568
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4.112 169.342 -2,37 166,99 -686.663 28.278.421
2020-07-02 2020-07-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1.300 173.454 -0,74 165,86 -215.618 28.769.080
2020-05-07 2020-05-05 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -26.867 0 -100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -1.103 0 -100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -2.268 0 -100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -2.436 0 -100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -2.554 0 -100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -3.831 0 -100,00
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3.831 173.888 2,25 26,10 99.989 4.538.477
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2.436 170.057 1,45 41,04 99.973 6.979.139
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2.268 167.621 1,37 44,09 99.996 7.390.410
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2.554 165.353 1,57 39,15 99.989 6.473.570
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1.103 162.799 0,68 45,30 49.966 7.374.795
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -1.200 161.696 -0,74 164,10 -196.920 26.534.314
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12.167 162.896 -6,95 163,36 -1.987.601 26.610.691
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -13.500 175.063 -7,16 162,45 -2.193.075 28.438.984
2020-05-06 2020-05-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 26.867 188.563 16,62 15,46 415.364 2.915.184
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -14.167 0 -100,00
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -14.167 161.696 -8,06 147,00 -2.082.556 23.769.393
2020-05-06 2020-05-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14.167 175.863 8,76 12,00 170.004 2.110.356
2020-04-21 2020-04-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
D - Sale to Issuer X -570 161.696 -0,35 139,92 -79.752 22.623.906
2020-04-21 2020-04-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 1.439 162.266 0,89
2020-04-21 2020-04-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 2.389 160.827 1,51
2019-12-23 2019-12-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 871 158.438 0,55
2019-10-15 2019-10-10 4 NLTX Neoleukin Therapeutics, Inc.
Stock Option (right to buy)
A - Award 22.000 22.000
2019-10-02 2019-09-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -15.000 157.567 -8,69 85,00 -1.275.000 13.393.195
2019-09-04 2019-09-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2.092 172.567 -1,20 70,80 -148.112 12.217.623
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 49.232 49.232
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 1.333 1.333
2019-09-04 2019-08-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 21.288 174.659 13,88
2019-08-30 2019-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5.909 153.371 -3,71 73,21 -432.624 11.228.966
2019-08-22 2019-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -12.500 159.280 -7,28 80,00 -1.000.000 12.742.400
2019-04-09 2019-04-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -10.437 171.780 -5,73 78,00 -814.086 13.398.840
2019-04-09 2019-04-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2.063 182.217 -1,12 78,00 -160.914 14.212.926
2019-03-06 2019-03-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -10.000 184.280 -5,15 75,00 -750.000 13.821.000
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 47.904 47.904
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 1.301 1.301
2018-09-04 2018-08-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 20.715 194.280 11,94
2018-08-29 2018-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5.427 173.565 -3,03 74,23 -402.856 12.884.042
2018-05-09 2018-05-07 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 15.000 15.000
2018-03-22 2018-03-20 4 SGEN SEATTLE GENETICS INC /WA
Non-qualified Stock Option (Right to buy)
A - Award 10.526 10.526
2017-11-03 2017-11-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -534 178.992 -0,30 61,59 -32.889 11.024.117
2017-11-03 2017-11-01 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -38.851 179.526 -17,79 60,90 -2.366.026 10.933.133
2017-09-08 2017-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -9.638 218.377 -4,23 52,00 -501.176 11.355.604
2017-08-30 2017-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4.937 228.015 -2,12 47,89 -236.455 10.920.664
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 55.344 55.344
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2.156 2.156
2017-08-18 2017-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 23.000 232.952 10,95
2017-05-10 2017-05-08 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 9.000 9.000
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 42.793 42.793
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2.207 2.207
2016-08-30 2016-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 18.000 209.445 9,40
2016-08-22 2016-08-22 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -3.991 191.445 -2,04 46,59 -185.943 8.919.557
2016-05-11 2016-05-09 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 7.500 7.500
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -6.468 0 -100,00
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -8.333 0 -100,00
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8.333 194.675 4,47 12,00 99.996 2.336.100
2015-10-01 2015-09-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 6.468 186.342 3,60 15,46 99.995 2.880.847
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 39.946 39.946
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2.554 2.554
2015-08-25 2015-08-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 17.000 179.874 10,44
2015-08-25 2015-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -5.825 162.874 -3,45 42,02 -244.794 6.844.731
2015-03-16 2015-03-12 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 5.000 5.000
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 40.232 40.232
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2.268 2.268
2014-08-27 2014-08-26 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 17.000 168.699 11,21
2014-08-27 2014-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -3.696 151.699 -2,38 43,55 -160.957 6.606.340
2014-03-10 2014-03-06 4 AQXP AQUINOX PHARMACEUTICALS, INC
Stock Option (Right to Buy)
A - Award 8.333 8.333
2014-03-06 3 AQXP AQUINOX PHARMACEUTICALS, INC
No securities are beneficially owned
0
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -8.223 0 -100,00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -9.017 0 -100,00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -13.126 0 -100,00
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 8.223 155.395 5,59 12,16 99.992 1.889.603
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9.017 147.172 6,53 11,09 99.999 1.632.137
2013-08-30 2013-08-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 13.126 138.155 10,50 10,29 135.067 1.421.615
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -12.500 21.169 -37,13
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -12.500 21.169 -37,13
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -4.166 26.867 -13,42
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2.972 0 -100,00
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -5.625 14.167 -28,42
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12.500 125.029 -9,09 41,45 -518.095 5.182.152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -12.500 125.029 -9,09 41,45 -518.095 5.182.152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12.500 137.529 10,00 26,10 326.250 3.589.507
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12.500 137.529 10,00 26,10 326.250 3.589.507
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -4.166 125.029 -3,22 41,45 -172.671 5.182.152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4.166 129.195 3,33 15,46 64.406 1.997.355
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -5.625 125.029 -4,31 41,45 -233.143 5.182.152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 5.625 130.654 4,50 12,00 67.500 1.567.848
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -2.972 125.029 -2,32 41,45 -123.182 5.182.152
2013-08-30 2013-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2.972 128.001 2,38 12,16 36.140 1.556.492
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 33.564 33.564 41,04 1.377.467 1.377.467
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 2.436 2.436 41,04 99.973 99.973
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 14.400 125.029 13,02
2013-08-21 2013-08-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -3.328 110.629 -2,92 40,91 -136.148 4.525.832
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -29.166 31.033 -48,45
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -18.361 19.792 -48,12
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -29.166 113.957 -20,38 37,94 -1.106.558 4.323.529
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 29.166 143.123 25,59 15,46 450.906 2.212.682
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -18.361 113.957 -13,88 37,94 -696.616 4.323.529
2013-07-15 2013-07-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 18.361 132.318 16,11 12,00 220.332 1.587.816
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -1.486 2.972 -33,33
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -43.514 38.153 -53,28
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -43.514 113.957 -27,63 36,94 -1.607.407 4.209.572
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 43.514 157.471 38,18 12,00 522.168 1.889.652
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1.486 113.957 -1,29 36,94 -54.893 4.209.572
2013-07-15 2013-07-11 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1.486 115.443 1,30 12,16 18.070 1.403.787
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -19.494 4.458 -81,39
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -682 0 -100,00
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -19.494 113.957 -14,61 30,70 -598.466 3.498.480
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 19.494 133.451 17,11 12,16 237.047 1.622.764
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -682 113.957 -0,59 30,70 -20.937 3.498.480
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 682 114.639 0,60 11,09 7.563 1.271.347
2013-03-08 2013-03-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -29.542 113.957 -20,59 30,78 -909.303 3.507.596
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -417 0 -100,00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -72.320 0 -100,00
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 417 143.499 0,29 5,63 2.348 807.899
2012-11-09 2012-11-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 72.320 143.082 102,20 5,20 376.064 744.026
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -50.000 23.952 -67,61
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -50.000 70.762 -41,40 28,97 -1.448.500 2.049.975
2012-09-07 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 50.000 120.762 70,66 12,16 608.000 1.468.466
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2.825 73.952 -3,68
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -42.175 682 -98,41
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2.825 70.762 -3,84 27,97 -79.015 1.979.213
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2.825 73.587 3,99 12,16 34.352 894.818
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -42.175 70.762 -37,34 27,97 -1.179.635 1.979.213
2012-09-07 2012-09-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 42.175 112.937 59,60 11,09 467.721 1.252.471
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -13.126 42.857 -23,45
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -17.874 0 -100,00
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -13.126 70.762 -15,65 26,97 -354.008 1.908.451
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 13.126 83.888 18,55 11,09 145.567 930.318
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -17.874 70.762 -20,17 26,97 -482.062 1.908.451
2012-08-27 2012-08-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 17.874 88.636 25,26 10,29 183.923 912.064
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -14.000 17.874 -43,92
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -14.000 70.762 -16,52 26,97 -377.580 1.908.451
2012-08-27 2012-08-24 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 14.000 84.762 19,78 10,29 144.060 872.201
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 46.169 46.169 26,10 1.205.011 1.205.011
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 3.831 3.831 26,10 99.989 99.989
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 20.000 70.762 39,40
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -40.000 31.874 -55,65
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -40.000 50.762 -44,07 25,97 -1.038.800 1.318.289
2012-08-20 2012-08-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 40.000 90.762 78,80 10,29 411.600 933.941
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -19.583 0 -100,00
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -30.417 0 -100,00
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -19.583 50.762 -27,84 24,97 -488.988 1.267.527
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 19.583 70.345 38,58 5,63 110.252 396.042
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -30.417 50.762 -37,47 24,97 -759.512 1.267.527
2012-06-14 2012-06-14 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 30.417 81.179 59,92 5,20 158.168 422.131
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -45.000 30.417 -59,67
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -45.000 50.762 -46,99 23,97 -1.078.785 1.216.917
2012-06-14 2012-06-12 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 45.000 95.762 88,65 5,20 234.000 497.962
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -35.000 75.417 -31,70
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -35.000 50.762 -40,81 22,97 -803.950 1.166.003
2012-06-08 2012-06-08 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 35.000 85.762 68,95 5,20 182.000 445.962
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 19.583 19.583 5,63 110.252 110.252
2006-02-01 2006-01-31 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 417 417 5,63 2.348 2.348
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)